Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
Tremblay, Gabriel, Dolph, Mike, Bhor, Menaka, Said, Qayyim, Elliott, Brian, Briggs, AndrewVolume:
Volume 10
Language:
english
Journal:
ClinicoEconomics and Outcomes Research
DOI:
10.2147/CEOR.S177324
Date:
November, 2018
File:
PDF, 238 KB
english, 2018